Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital

Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Detecting immunoglobulins in processed sputa

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cold urticaria - What we know and what we do not know

    Research output: Contribution to journalReviewResearchpeer-review

  4. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Emek Kocatürk
  • Mona Al-Ahmad
  • Karoline Krause
  • Ana M Gimenez-Arnau
  • Simon Francis Thomsen
  • Niall Conlon
  • Alexander Marsland
  • Ekin Savk
  • Roberta F Criado
  • Inna Danilycheva
  • Daria Fomina
  • Kiran Godse
  • Maryam Khoshkhui
  • Aslı Gelincik
  • Ece Nur Degirmentepe
  • Semra Demir
  • Luis Felipe Ensina
  • Alicja Kasperska-Zajac
  • Michael Rudenko
  • Solange Valle
  • Iris Medina
  • Andrea Bauer
  • Zuotao Zhao
  • Petra Staubach
  • Laurence Bouillet
  • Özlem Su Küçük
  • Can Ateş
  • Marcus Maurer
View graph of relations

BACKGROUND: Chronic urticaria (CU) predominantly affects women, and sex hormones can modulate disease activity in female CU patients. As of now, the impact of pregnancy on CU is largely unknown.

AIM: To analyze the course and features of CU during and after pregnancy.

PATIENTS AND METHODS: PREG-CU is an international, multicenter study of the Urticaria Centers of Reference and Excellence (UCARE) network. Data were collected via a 47-item questionnaire completed by CU patients, who became pregnant within the last 3 years.

RESULTS: A total of 288 pregnancies of 288 CU patients from 13 countries were analyzed (mean age at pregnancy: 32.1 ± 6.1 years, duration of CU: 84.9 ± 74.5 months; CSU 66.9%, CSU + CIndU 20.3%, CIndU 12.8%).During pregnancy, 51.1% of patients rated their CU as improved, 28.9% as worse, and 20.0% as unchanged.CU exacerbations most commonly occurred exclusively during the third trimester (in 34 of 124 patients; 27.6%) or the first (28 of 124; 22.8%). The risk factors for worsening of CU during pregnancy were having mild disease and no angioedema before pregnancy, not taking treatment before pregnancy, CIndU, CU worsening during a previous pregnancy, treatment during pregnancy, and stress as a driver of exacerbations. After giving birth, urticaria disease activity remained unchanged in 43.8% of CU patients, whereas 37.4% and 18.1% experienced worsening and improvement, respectively.

CONCLUSIONS: These results demonstrate the complex impact of pregnancy on the course of CU and help to better counsel patients who want to become pregnant and to manage CU during pregnancy.

Original languageEnglish
Issue number10
Pages (from-to)3133-3144
Number of pages12
Publication statusPublished - Oct 2021

Bibliographical note

© 2021 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

    Research areas

  • Angioedema, Chronic Disease, Chronic Urticaria, Female, Gonadal Steroid Hormones, Humans, Pregnancy, Surveys and Questionnaires, Urticaria/epidemiology

ID: 72967516